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ABSTRACT
Introduction: Although the association between periodontal disease (PD) and adverse pregnancy
outcomes has gained recognition amongst antenatal healthcare workers, not much has changed in
practice to address it. This prospective study tested the hypothesis that BANA (N-benzoyl-DL-arginine-
2-naphthylamide), a diagnostic test for PD, may inform obstetricians and other antenatal healthcare
practitioners, of the risk of adverse pregnancy outcomes in mothers attending antenatal clinics.
Methods: At first visit, the presence of suspected periodontopathogens was assessed by BANA testing
of dental plaque from 443 mothers attending antenatal clinics in KwaZulu-Natal, South Africa and an
association later sought with pregnancy outcomes. The accuracy of BANA to predict adverse pregnancy
outcomes was evaluated by the calculation of likelihood ratios. The study complied with the
Declaration of Helsinki.
Results: Significant differences were found between pregnancy outcomes of BANA-negative and
BANA-positive mothers (p< 0.0001). BANA showed sensitivity and negative predictive values of 87%
and 91%; 75% and 78%; 87% and 94% in detecting low birth weight, preterm delivery, and preterm
low birth weight delivery respectively.
Conclusion: This study confirms that BANA may indicate the need for periodontal therapy to reduce
the risk of adverse pregnancy outcomes and could form part of the routine antenatal examination.
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Adverse pregnancy outcomes such as preterm birth (PTB)
and low birth weight (LBW) are major causes of maternal
and neonatal morbidity and mortality. Increasing evidence
points to an association between periodontal disease (PD)
and adverse pregnancy outcomes and thus early detection
will assist in treatment planning to reduce adverse pregnancy
outcomes. It has been reported that 50%–70% of pregnant
women develop PD between the second and eighth month
of pregnancy (Barak et al. 2007, Leon et al. 2007). However,
recent studies show that oral health assessment does not
form part of the routine antenatal screening, resulting in
many cases of maternal PD going undetected (Wilder et al.
2007, Thomas et al. 2008, Da Rocha et al. 2011, Suri et al.
2014). Although there appears to be an awareness of the
association of PD with adverse pregnancy outcomes, very lit-
tle is being done to address it and thus mothers with poor
oral health are often not detected nor granted the opportun-
ity of being referred for dental therapy to reduce their risk of
adverse pregnancy outcomes.
Treponema denticola, Porphyromonas gingivalis and
Tannerella forsythia, collectively known as the red complex
(Socransky et al. 1998), are bacterial species which have con-
sistently been implicated in the aetiology of PD and are
known to produce a trypsin-like enzyme capable of hydrolys-
ing the substrate N-benzoyl-DL-arginine-2-naphthylamide,
commonly referred to as BANA (Loesche et al. 1992). BANA
has thus gained recognition as a diagnostic tool for PD
through its ability to detect these species in dental plaque
samples with the same accuracy as DNA probes (Loesche
et al. 1992, Andrade et al. 2010).
Bayingana (2005) used BANA and PCR (polymerase chain
reaction) to investigate the prevalence of the red complex in
subgingival plaque samples in pregnant women and after
associating these results with pregnancy outcomes, proposed
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the wider use of BANA as a screening test for mothers at risk
for delivering preterm or LBW infants. After controlling for
other risk factors, Chan et al. (2010) also found an association
between PTB and BANA-positive plaques, thus lending sup-
port to this thesis. However, to date, there has been very lit-
tle other support for this association, despite these
significant findings.
This study aimed to inform obstetricians and other health-
care practitioners in antenatal clinics of the value of BANA as
a point of care test (outside the dental environment) to
detect potential periodontal pathogens and to reduce the
risk of adverse pregnancy outcomes due to PD. It completes
an earlier study which associated clinically diagnosed PD
with pregnancy outcomes (Turton and Africa 2017), by using
the BANA test to indicate the presence of suspected peri-
odontal pathogens in these subjects.
Clinical significance
 Periodontal disease (PD) has been associated with adverse
pregnancy outcomes, but not enough is being done to
forge the collaboration between antenatal healthcare pro-
viders and oral healthcare professionals. The implementa-
tion of BANA (a diagnostic test for PD) as a routine point
of care test at the start of an antenatal examination may
deliver a result by the time her examination is complete.
This will alert antenatal healthcare providers of any risk
for adverse pregnancy outcomes and encourage them to




The study included 443 randomly selected pregnant women
aged18 years, presenting at antenatal maternal obstetric
units (MOU) in the province of KwaZulu-Natal in South Africa
over a two-year period. Calculation of the estimates of the
variance available from other studies revealed that 400 (±10)
samples would be an adequate sample size, given a 95%
confidence interval. Non-probability sampling was employed
to select the sites where pregnant women were enrolled
using convenience sampling. Excluded from the study were
smokers; patients with existing heart disease, hypertension,
diabetes, asthma or chronic renal disease; mothers with
induced labour, previous preterm delivery or multiple preg-
nancies; mothers currently using systemic corticosteroids or
antibiotics, all of which may have influenced the outcomes
of the study.
Ethical considerations
The study complied with the Declaration of Helsinki (WMA
2013) and was ethically approved by the research ethics
committee of the University of the Western Cape. The
Provincial Department of Health and the Municipal health
district managers granted permission for the research to
be conducted at the various hospitals and clinics selected.
Individuals submitted signed consent for participation in
the study after the nature of the study was explained to
them. Those who were unable to read or write had the
contents of the consent forms explained to them and indi-
cated their consent by means of an ‘X’ on the signature
line.
Data collection
A cross sectional study structure was used with data collec-
tion in a standardized format using a structured question-
naire along with clinical data capture sheets. The
questionnaire elicited demographic information about the
participants and contained items designed to obtain informa-
tion regarding factors which may predispose for PD such as
medical history, maternal age, stage of pregnancy and per-
sonal hygiene practices (including oral hygiene). The gesta-
tional age of the participant, at the time of enrolment, was
calculated from the date of the last menstrual period. This
information was verified by cross referencing it with the par-
ticipant’s MOU file.
The presence and severity of PD was graded as absent,
mild, moderate, or severe as described by Offenbacher et al.
(2001).
For the BANA assay, an interdental subgingival plaque
sample was collected with a periodontal probe between the
first molar and second premolar of each quadrant of the
mouth, or, if one of these teeth was missing, then between
either the first and second molars, or between the premolars
(Loesche et al. 1990).
The site from which the sample was collected was
recorded on the BANA test card (PerioscanVR , Oral-B
Laboratories Inc., Redwood City, CA), in the marked space.
Briefly, the principle of the test is as follows. The BANA
hydrolysis test is a plastic card with two separate reagent
matrices (strips). The lower strip is impregnated with BANA
reagent and the upper strip contains a chromogenic diazo
reagent, Fast Black K B-naphthylamide. One of the hydro-
lytic products of the BANA reaction reacts with the Fast
Black K producing a permanent blue colour (Loesche et al.
1990).
Following plaque collection, the tip of the periodontal
probe containing the plaque was wiped onto the BANA-
impregnated lower strip, located on the bottom of the BANA
reagent card. The reaction was immediately activated by
water applied to the upper strip containing the fast black
dye. The lower strip was folded onto the upper strip and
both strips were held in place with a metallic clip while incu-
bated at 55 C for 15min in the BANA incubator (Model
KPT01, Knowell Periodontal Technologies, Inc., Toronto,
Canada). The result of the BANA analysis was recorded as
positive (blue spots at the sample site on the reagent card)
or negative (no colour change) on the data capture sheet
(Loesche et al. 1990).
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Pregnancy outcomes
Post-delivery, gestational age, infant weight and mode of
delivery were recorded. Infants with birth weight
(BW)< 2500 g were classified as LBW and those delivered
before 37-week gestation were classified as PTB. Infants born
both preterm (<37 weeks) and with LBW (<2500 g) were
classified in the category preterm LBW (PTLBW).
Data analysis
The STARD checklist and flow chart for studies of diagnostic
accuracy (Bossuyt et al. 2015) were employed to ensure
accurate reporting of the data. Descriptive statistics were
derived from demographic and socio-economic data. The
diagnostic accuracy of BANA in predicting PTB and LBW was
determined by measurement of the area under the curve
(AUC) in a receiver operating characteristic (ROC) curve ana-
lysis and by calculating the sensitivity, specificity, predictive
values and likelihood ratios.
MedCalc Statistical Software version 17.1 (MedCalc
Software bvba, Ostend, Belgium) was used to perform the
statistical analyses. After examining for normal distribution of
the data by means of the Chi-squared test, non-parametric
tests (Spearman rank correlation, Mann–Whitney test and
Kruskal–Wallis test) were applied. Statistical significance was
defined as p< 0.05.
Results
The participants ranged in age between 18 and 42 years with
a mean (SD) age of 24.13 (±5.30) years. Pregnancy stage var-
ied, with 62.3% in their second trimester of pregnancy, 33.4%
in the third trimester and 4.2% in the first trimester.
BANA
A description of the clinical presentation of PD status of
these mothers is published elsewhere (Turton and Africa
2017), and will not be repeated here. In line with the PD
grading, 282 (64%) of the mothers produced a positive BANA
test result, while BANA-negative mothers constituted 161 of
the 443 subjects recruited to this study (36%).
BANA was significantly associated with the presence of PD
in these mothers as revealed by Chi-squared analysis
(X2¼260.3, df¼ 3, p< 0.0001, Table 1). As the severity of PD
increased from mild to severe, the number of BANA-negative
plaques decreased (Table 1). On the other hand, the number
of BANA-positive plaques was low in the absence of PD and
increased in patients with PD (Table 1).
Pregnancy outcomes
Birth outcomes in terms of gestational age (r¼ 0.230), BW
(r¼ 0.491) and BW for gestational age (r¼ 0.409) showed
a significant negative correlation (p< 0.0001) with PD
status.
The mean gestational age (GA) was 37.32weeks (SD¼ 2.5,
Min¼ 22, Max¼ 40). The Kruskal–Wallis test showed that GA
and BW differed significantly (p< 0.0001) with PD status (i.e.
from absent to severe) and between BANA-positive and
BANA-negative samples (Figure 1(a,b), respectively). Since not
all BANA-negative samples indicated an absence of PD, and
since not all BANA-positive samples indicated PD (Table 1),
we elected to group samples into two groups, namely BANA-
positive/PD-positive, and BANA-negative/PD-negative, in
order to compare their pregnancy outcomes. A significant
difference between the two groups was observed for both
gestational age and BW (Figure 1(c)).
Seventy-five per cent (107/142) of the mothers who deliv-
ered PTB (i.e.<37-week gestation) were BANA-positive, while
78.3% (126/161) of the mothers who were BANA-negative
delivered full term (FTB, Table 2). Chi-squared analysis
revealed significant differences between PTB and FTB for
BANA (p< 0.0001).
One hundred and nine mothers delivered LBW infants of
whom 95 (87.2%) were BANA-positive (Table 2). Of the
mothers who tested BANA-negative, 91% (147/161) deliv-
ered infants of normal birth weight (NBW). BANA compari-
sons for LBW and NBW differed significantly (p< 0.0001).
This significance remained when the BW and gestational
age were combined and classified as preterm LBW (PTLBW)
and full term NBW (FTNBW). Of the 71 infants classified as
PTLBW, 62 (87%) were BANA-positive while 94% of those
born of mothers with a negative BANA were born FTNBW
(Table 2).
Evaluation of BANA as a screening test for pregnancy
outcomes
The evaluation of BANA as a screening test for poor preg-
nancy outcomes revealed a positive likelihood ratio (LRþ) of
>1 for PD, preterm (PTB), LBW and preterm LBW (PTLBW).
BANA showed a sensitivity of 86% for predicting PD
(CI¼ 82%–89%), 75% for preterm (CI¼ 67%–82%), 87%
(CI¼ 79%–92%) for LBW and 87% (CI¼ 77%–94%) for PTLBW
(Table 3). Although the positive predictive value (PPV) was
only high for PD, a good negative predictive value (NPV) and
negative likelihood ratio (LR-) of <1 was demonstrated for
PD, PTB, LBW and PTLBW (Table 3).
Figure 2 shows the ROC–curve comparison of BANA with
each of the reference standards used, namely, PD, BW, GA
and BW for gestational age (BWGA). The standard methods
used for establishing these outcomes are outlined in the
methodology section above. AUC measurement of the
ROC–curve analysis revealed that BANA accurately predicted
PD (AUC¼ 0.895, p< 0.0001) and was a better predictor of
BW (AUC¼ 0.697; p< 0.0001) and BWGA (AUC¼ 0.669;
p< 0.0001) than GA (AUC¼ 0.621; p¼ 0.002).
Table 1. The association of BANA with periodontal disease status.
Periodontal disease
BANA (n¼ 443) Absent Mild Moderate Severe
Negative (n¼ 161) 117 38 5 1
Positive (n¼ 282) 6 155 76 45
Chi-squared test revealed that as periodontal disease severity increased, the




PD is a common complication of pregnancy, and until
recently has not received the attention it deserves as a risk
indicator for poor pregnancy outcomes. Microbiological tech-
niques used to diagnose PD include microscopy, culture and
more recently, molecular techniques, all of which are expen-
sive and time-consuming and cannot be conducted in a rou-
tine clinical setting.
The accuracy of BANA to detect PD has already been well
established (Loesche et al. 1992), showing good sensitivity
Figure 1. Association of pregnancy outcomes with periodontal disease and BANA. (a) There is a highly significant (p< 0.0001) correlation between gestational age/
birth weight and periodontal disease status with gestational age and birth weight declining significantly with increased periodontal disease severity. (b)
Kruskal–Wallis test shows highly significant (p< 0.0001) differences in gestational age and birth weight in infants born of BANA-positive and BANA-negative moth-
ers. (c) Number of BANA-positive and BANA-negative subjects with and without periodontal disease.
Table 2. Comparison of normal and adverse pregnancy outcomes with BANA.














BANAþn¼ 279 107 (24.3) 172 (39) 95 (21.5) 184 (42) 62 (14) 217 (49.3)
BANA – n¼ 161 35 (7.9) 126 (8.6) 14 (3.2) 147 (33.3) 9 (2) 152 (34.5)
Total N¼ 440 142 (32.2) 298 (67.7) 109 (24.7) 331 (75.3) 71 (16) 369 (83.8)
Missing ¼3.











Sensitivity 86% 75% 87% 87%
Specificity 95% 42% 44% 41%
LR1 17.6 1.3 1.5 1.5
LR- 0.1 0.6 0.3 0.3
PPV 98% 38% 34% 22%
NPV 73% 78% 91% 94%
Confidence intervals (CI)¼ 95%. LRþ¼ positive likelihood ratio;
LR¼ negative likelihood ratio; PPV¼ positive predictive value;
NPV¼ negative predictive value.
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and specificity when compared with DNA probes and poly-
clonal immunological reagents (92% and 70%, respectively),
and 95% sensitivity when compared with chequerboard
DNA–DNA hybridization using highly specific whole genomic
DNA probes to P. gingivalis, T. forsythia and T. denticola. It is
thus recognized in epidemiologic studies as a diagnostic tool
for PD (Loesche et al. 1992) and associated infections (Bretz
et al. 1993; Grisi et al. 2001; Loesche et al. 1998).
A strength of this study is that the mean BW of infants
born of BANA-negative and BANA-positive mothers differed
significantly, as did the gestational age and BWGA. BANA
showed a sensitivity of 87% and a NPV of 91% in detecting
LBW, a sensitivity of 75% and NPV of 78% in detecting PTB,
and a sensitivity of 87% with a NPV of 94% for PTLBW,
thereby demonstrating the usefulness of the BANA test as a
screening test for mothers at risk for preterm delivery of LBW
infants. Although we were unable to record the pregnancy
outcomes of three of the patients originally recruited to the
study, we did not consider this a limitation since we had
made allowance for attrition by exceeding the number of
subjects originally decided upon. We speculate that the find-
ing of BANA-positive results in the absence of PD in this
study may be due to bacteria other than the red complex,
such as Rothia and Capnocytophaga species, which are also
known to be BANA-positive, but unlike the red complex,
have not consistently been associated with PD (Loesche et al.
1990).
There is a controversy around the benefit of dental treat-
ment during pregnancy with some studies reporting a reduc-
tion in adverse pregnancy outcomes (Slots and Research,
Science and Therapy Committee 2004, Lopez et al. 2005),
and others showing no benefit (Michalowicz et al. 2006,
Newnham et al. 2009, Offenbacher et al., 2009, Macones et al.
2010, Jeffcoat et al. 2011). However, the argument in favour
of treatment far outweighs the argument against it. It has
been confirmed by the American Academy of Periodontology
(Rubenfire et al. 2007) that treatment for PD during the
second trimester of pregnancy is not only beneficial but also
safe and effective.
Unfortunately, not many mothers seek dental treatment
during pregnancy and antenatal clinics pay little if any atten-
tion to the oral health status of the mother, with the result
that this complication often goes undetected. Surveys con-
ducted in USA, Brazil and India on the knowledge and prac-
tice behaviours of obstetricians reveal an increasing
awareness amongst obstetricians of an association of PD
with adverse pregnancy outcomes while simultaneously sug-
gesting that a change in attitude is needed to adequately
address the risk (Da Rocha et al. 2011, Suri, Rao and
Aggarwal 2014, Wilder et al. 2007).
In the survey conducted in North Carolina, USA (Wilder
et al. 2007), 84% of obstetricians recognized PD as a risk fac-
tor for adverse pregnancy outcomes; only 22% admitted
examining patients’ mouths at first visit, while the remainder
reported either doing an oral examination periodically (9%),
or when a problem was reported by a patient (48%). Forty-
nine per cent reported that they rarely if ever, recommended
a dental examination. A later survey of the same region by
Thomas et al. (2008), involving nurse practitioners, physician
assistants and certified midwives, looked more encouraging
and revealed that 63% reported looking in the patient’s
mouth to screen for oral problems at the initial visit, 20% felt
that their knowledge of PD was current, and all agreed that
their discipline should receive instruction regarding PD.
Ninety-five per cent agreed that a collaborative effort
between the healthcare provider and the oral healthcare pro-
fessionals was needed and would reduce the patient’s risk of
having an adverse pregnancy outcome.
In Brazil, 80% of obstetricians surveyed, believed that PD
was a risk factor for poor pregnancy outcomes (Da Rocha et al.
2011) while only 30%–52% (influenced by increasing years of
practical experience) referred their patients for dental examina-
tions during pregnancy. Similar results were reported from
India (Suri, Rao and Aggarwal 2014) where 70% of obstetricians
recognized the effects of poor dental health on pregnancy out-
comes, but only 40% advised their patients on the need for
routine dental examination during pregnancy.
It is evident from the above that even though the import-
ance of oral health during pregnancy is acknowledged, not
enough is being done to forge the collaboration between
the antenatal healthcare provider and oral healthcare profes-
sionals. One of the reasons given for this lack of action is the
limited time for consultation, leaving no time to perform an
oral examination (Wilder et al. 2007). This can be overcome
Figure 2. Comparison of ROC curves to determine the accuracy of BANA in pre-
dicting periodontal disease and pregnancy outcomes. Details of each of the ref-
erence standards compared with BANA, namely, birth weight, gestational age
and birth weight for gestational age, are outlined in the methodology section
of this paper. BANA predicted periodontal disease most accurately
(AUC¼ 0.895; p< 0.0001), followed by birth weight (AUC¼ 0.697, p< 0.0001)
and birth weight for gestational age (AUC¼ 0.669; p< 0.0001) with gestational
age showing the lowest AUC (AUC¼ 0.621, p¼ 0.002).
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by incorporating a rapid point of care test such as BANA into
the routine antenatal examinations. This could alert antenatal
healthcare providers of the risk of adverse pregnancy out-
comes and encourage them to refer mothers to a dental
clinic for prompt treatment to reduce their risk and improve
their own health and general wellbeing as well as the well-
being of their infants.
BANA is a simple, rapid and inexpensive point of care test,
if set up prior to the start of the patient’s examination, which
can deliver a result by the time her examination is complete.
Although a periodontal probe was used in this study to col-
lect plaque from between the teeth, a sterile wooden tooth-
pick will work as efficiently, thus lending this technique to
use outside of the dental clinic. In addition, the size of the
BANA incubator is relatively small (16.5 13 cm) and can eas-
ily be accommodated in a clinical setting.
Limitations of the study include the difficulty in making
comparisons with other studies due to differences in
(amongst others) sampling techniques, diagnostic criteria,
pregnancy stage at recruitment, ethnicity and geographical
location. Within the limitations of the study, the findings sup-
port the hypothesis that a positive BANA test during preg-
nancy may have a significant association with negative
pregnancy outcomes such as miscarriage, PTB and LBW. Its
implementation as a chairside screening test during antenatal
visits should be considered.
Conclusion
This study is one of very few studies which examined for
potential periodontal pathogens in mothers attending ante-
natal clinics, using a simple and rapid point of care test
(BANA) which reliably identified mothers at risk for preterm
delivery of LBW infants. Since the objective of the current
study was to inform healthcare practitioners in antenatal clin-
ics of the predictive value of BANA as a point of care test for
detecting maternal PD outside of the dental environment
with the purpose of referring them to a dentist for treatment,
a prospective randomized treatment study is needed to
prove that prompt treatment of PD following BANA testing
of mothers may significantly reduce the preterm delivery of
LBW infants.
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